Big data in IBD: big progress for clinical practice
暂无分享,去创建一个
Padhmanand Sudhakar | Matthew Madgwick | Tamas Korcsmaros | Nasim Sadat Seyed Tabib | Bram Verstockt | Séverine Vermeire | S. Vermeire | T. Korcsmáros | N. S. Seyed Tabib | P. Sudhakar | B. Verstockt | M. Madgwick
[1] Ahmed Enayetallah,et al. Robust clinical outcome prediction based on Bayesian analysis of transcriptional profiles and prior causal networks , 2014, Bioinform..
[2] P. Higgins,et al. Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines , 2017, Journal of Crohn's & colitis.
[3] Ryan W. Stidham,et al. Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis , 2019, JAMA network open.
[4] Leonard W. D'Avolio,et al. Evaluation of a generalizable approach to clinical information retrieval using the automated retrieval console (ARC) , 2010, J. Am. Medical Informatics Assoc..
[5] Morteza Mohammad Noori,et al. Enhanced Regulatory Sequence Prediction Using Gapped k-mer Features , 2014, PLoS Comput. Biol..
[6] Marc-Thorsten Hütt,et al. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease , 2016, Gut.
[7] Andrew Kusiak,et al. Data mining and genetic algorithm based gene/SNP selection , 2004, Artif. Intell. Medicine.
[8] K. Weigel,et al. Machine learning classification procedure for selecting SNPs in genomic selection: application to early mortality in broilers. , 2007, Developments in biologicals.
[9] Maria Victoria Schneider,et al. Next generation of network medicine: interdisciplinary signaling approaches. , 2017, Integrative biology : quantitative biosciences from nano to macro.
[10] Zhen Lin,et al. Choosing SNPs using feature selection , 2005, 2005 IEEE Computational Systems Bioinformatics Conference (CSB'05).
[11] Julio Saez-Rodriguez,et al. OmniPath: guidelines and gateway for literature-curated signaling pathway resources , 2016, Nature Methods.
[12] Ofer Isakov,et al. Machine Learning–Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.
[13] H. Riper,et al. Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis , 2018, Journal of medical Internet research.
[14] R. Caprioli,et al. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis , 2013, Proteomics. Clinical applications.
[15] Nataša Pržulj,et al. Methods for biological data integration: perspectives and challenges , 2015, Journal of The Royal Society Interface.
[16] J. Grimsby,et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues , 2019, Science.
[17] G. Su,et al. Assessing Small Bowel Stricturing and Morphology in Crohn's Disease Using Semi-automated Image Analysis. , 2019, Inflammatory bowel diseases.
[18] Dongsup Kim,et al. Inferring Crohn’s disease association from exome sequences by integrating biological knowledge , 2016, BMC Medical Genomics.
[19] Joaquín Dopazo,et al. Prophet, a web-based tool for class prediction using microarray data , 2007, Bioinform..
[20] Miles Parkes,et al. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. , 2011, The Journal of clinical investigation.
[21] Judy H. Cho,et al. [Letters to Nature] , 1975, Nature.
[22] M. Kaplan,et al. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases , 2018, Front. Immunol..
[23] J. Stoker,et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. , 2018, Journal of Crohn's & colitis.
[24] Christopher F. Martin,et al. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[25] Cynthia Rudin,et al. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead , 2018, Nature Machine Intelligence.
[26] Ji Won Kim,et al. RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohn's Disease Patients Compared with Normal Mucosa of Healthy Controls , 2017, Inflammatory bowel diseases.
[27] Russ B. Altman,et al. A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease , 2017, Bioinform..
[28] Jenny Sauk,et al. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.
[29] T. Vatanen,et al. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease , 2016, Genome Medicine.
[30] S. Horvath,et al. Statistical Applications in Genetics and Molecular Biology , 2011 .
[31] B. Frey,et al. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning , 2015, Nature Biotechnology.
[32] James T. Morton,et al. Impacts of the Human Gut Microbiome on Therapeutics. , 2018, Annual review of pharmacology and toxicology.
[33] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[34] Judy H. Cho,et al. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data , 2019, Scientific Reports.
[35] Kai-Yao Huang,et al. Increase Trichomonas vaginalis detection based on urine routine analysis through a machine learning approach , 2019, Scientific Reports.
[36] Edsel A Peña,et al. Dynamic Modelling and Statistical Analysis of Event Times. , 2006, Statistical science : a review journal of the Institute of Mathematical Statistics.
[37] M. Schmitt,et al. Classification of inflammatory bowel diseases by means of Raman spectroscopic imaging of epithelium cells. , 2012, Journal of biomedical optics.
[38] Dursun Delen,et al. Predicting and explaining inflammation in Crohn’s disease patients using predictive analytics methods and electronic medical record data , 2019, Health Informatics J..
[39] Timothy L. Tickle,et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.
[40] R. Xavier,et al. Multiomics Analyses to Deliver the Most Effective Treatment to Every Patient With Inflammatory Bowel Disease. , 2018, Gastroenterology.
[41] Richard Hansen,et al. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease , 2018, Microbiome.
[42] X. Jiang,et al. Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease. , 2015, European review for medical and pharmacological sciences.
[43] Aviv Regev,et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.
[44] Alberto D. Pascual-Montano,et al. A survey of dimensionality reduction techniques , 2014, ArXiv.
[45] Wei Zhang,et al. Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. , 2018, Cell systems.
[46] Francisco Guarner,et al. The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.
[47] Leontios J Hadjileontiadis,et al. Potential of hybrid adaptive filtering in inflammatory lesion detection from capsule endoscopy images , 2016, World journal of gastroenterology.
[48] Kevin S. Bonham,et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.
[49] Jun Yu,et al. Gut mucosal virome alterations in ulcerative colitis , 2019, Gut.
[50] Akbar K Waljee,et al. Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning. , 2017, Inflammatory bowel diseases.
[51] David J. Hand,et al. Classifier Technology and the Illusion of Progress , 2006, math/0606441.
[52] J. Zhu,et al. Predicting corticosteroid‐free endoscopic remission with vedolizumab in ulcerative colitis , 2018, Alimentary pharmacology & therapeutics.
[53] P. Schloss,et al. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients , 2018, mBio.
[54] A. Toubert,et al. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. , 2007, Gastroenterology.
[55] Sijian Wang,et al. Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[56] J. Stoker,et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. , 2018, Journal of Crohn's & colitis.
[57] S. Vermeire,et al. Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's disease , 2019, Alimentary pharmacology & therapeutics.
[58] D. Iliopoulos,et al. Environmental triggers in IBD: a review of progress and evidence , 2018, Nature Reviews Gastroenterology & Hepatology.
[59] Shawn N Murphy,et al. The Association Between Arthralgia and Vedolizumab Using Natural Language Processing. , 2018, Inflammatory bowel diseases.
[60] Leonard W. D'Avolio,et al. Automated Identification of Surveillance Colonoscopy in Inflammatory Bowel Disease Using Natural Language Processing , 2013, Digestive Diseases and Sciences.
[61] S. Szymczak,et al. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease , 2015, PloS one.
[62] P. Rutgeerts,et al. Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease. , 2019, Journal of Crohn's & colitis.
[63] K. Ngiam,et al. Big data and machine learning algorithms for health-care delivery. , 2019, The Lancet. Oncology.
[64] S. Vermeire,et al. New treatment options for inflammatory bowel diseases , 2018, Journal of Gastroenterology.
[65] A. Villani,et al. IL-12 and mucosal CD14+ monocyte-like cells induce IL-8 in colonic memory CD4+ T cells of patients with Ulcerative colitis but not Crohn's disease. , 2019, Journal of Crohn's & colitis.
[66] Keith W. Jones,et al. Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis , 2012, PloS one.
[67] M. Huss,et al. A primer on deep learning in genomics , 2018, Nature Genetics.
[68] Sunghwan Sohn,et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications , 2010, J. Am. Medical Informatics Assoc..
[69] Se Jin Song,et al. The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.
[70] H. Hakonarson,et al. Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. , 2013, American journal of human genetics.
[71] Qiu Zhao,et al. WGCNA Reveals Key Roles of IL8 and MMP-9 in Progression of Involvement Area in Colon of Patients with Ulcerative Colitis , 2018, Current Medical Science.
[72] S. Vermeire,et al. Scoring endoscopic disease activity in IBD: artificial intelligence sees more and better than we do , 2019, Gut.
[73] C. Urban,et al. Evasion of Immune Surveillance in Low Oxygen Environments Enhances Candida albicans Virulence , 2018, mBio.
[74] Masa Umicevic Mirkov,et al. Genetics of inflammatory bowel disease: beyond NOD2. , 2017, The lancet. Gastroenterology & hepatology.
[75] T. Ideker,et al. A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.
[76] Tamás Korcsmáros,et al. Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex , 2017, Genom. Proteom. Bioinform..
[77] Ashwin N. Ananthakrishnan,et al. Epidemiology and risk factors for IBD , 2015, Nature Reviews Gastroenterology &Hepatology.
[78] Yu-Dong Cai,et al. Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach , 2017, BioMed research international.
[79] F. Agakov,et al. Application of high-dimensional feature selection: evaluation for genomic prediction in man , 2015, Scientific Reports.
[80] Eddy J. Bautista,et al. Longitudinal multi-omics of host–microbe dynamics in prediabetes , 2019, Nature.
[81] Lisa M Bramer,et al. Dynamics of the human gut microbiome in Inflammatory Bowel Disease , 2017, Nature Microbiology.
[82] Tom Eelbode,et al. Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density , 2020, Gut.
[83] Edoardo Pasolli,et al. Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights , 2016, PLoS Comput. Biol..
[84] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[85] M. Tremelling,et al. A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in a complex disease , 2019, bioRxiv.
[86] D. Hommes,et al. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial , 2017, The Lancet.
[87] I. Kohane,et al. Improving Case Definition of Crohn's Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing: A Novel Informatics Approach , 2013, Inflammatory bowel diseases.
[88] Gregory D. Hager,et al. Assessment of Crohn’s Disease Lesions in Wireless Capsule Endoscopy Images , 2012, IEEE Transactions on Biomedical Engineering.
[89] S. Horvath,et al. Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease , 2016, Cellular and molecular gastroenterology and hepatology.
[90] Liu Hong,et al. Role of MiRNAs in Inflammatory Bowel Disease , 2017, Digestive Diseases and Sciences.
[91] Tariq Ahmad,et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study , 2016, The Lancet.
[92] Cesare Furlanello,et al. Phylogenetic convolutional neural networks in metagenomics , 2017, BMC Bioinformatics.
[93] O. Troyanskaya,et al. Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.
[94] Viju Raghupathi,et al. Big data analytics in healthcare: promise and potential , 2014, Health Information Science and Systems.
[95] Jaap Stoker,et al. A computer-assisted model for detection of MRI signs of Crohn’s disease activity: future or fiction? , 2011, Abdominal Imaging.
[96] Marc-Thorsten Hütt,et al. Distinct metabolic network states manifest in the gene expression profiles of pediatric inflammatory bowel disease patients and controls , 2016, Scientific Reports.
[97] Tariq Ahmad,et al. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease , 2017, Nature Genetics.
[98] David R. Kelley,et al. Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks , 2015, bioRxiv.
[99] Joachim M. Buhmann,et al. Semi-Supervised and Active Learning for Automatic Segmentation of Crohn's Disease , 2013, MICCAI.
[100] Loukas Moutsianas,et al. Exploring the genetic architecture of inflammatory bowel disease , 2016 .
[101] Brandi L. Cantarel,et al. Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease , 2012, PloS one.
[102] C. Fiocchi,et al. Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.
[103] J. Gisbert,et al. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry , 2017, The American Journal of Gastroenterology.
[104] Diogo M. Camacho,et al. Next-Generation Machine Learning for Biological Networks , 2018, Cell.
[105] D. Hommes,et al. Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease , 2017, BMJ Open.
[106] Mahmoud Torabinejad,et al. Cytotoxicity and Antimicrobial Effects of a New Fast-Set MTA , 2017, BioMed research international.
[107] Leroy Hood,et al. Systems Approaches to Biology and Disease Enable Translational Systems Medicine , 2012, Genom. Proteom. Bioinform..
[108] Sharon I. Greenblum,et al. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease , 2011, Proceedings of the National Academy of Sciences.
[109] Xiaohang Wu,et al. Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial , 2019, EClinicalMedicine.
[110] Xavier Llor,et al. Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling , 2013, PloS one.
[111] S. Vermeire,et al. Differential diagnosis of inflammatory bowel disease: imitations and complications. , 2018, The lancet. Gastroenterology & hepatology.
[112] Eddy J. Bautista,et al. Integrative Personal Omics Profiles during Periods of Weight Gain and Loss. , 2018, Cell systems.
[113] R. Sartor,et al. Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery. , 2018, Inflammatory bowel diseases.
[114] Liming Wang,et al. An artificial intelligence platform for the multihospital collaborative management of congenital cataracts , 2017, Nature Biomedical Engineering.
[115] Richard Bonneau,et al. Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells , 2017, Inflammatory bowel diseases.
[116] J. Danesh,et al. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease , 2017, Mucosal Immunology.
[117] Akbar K Waljee,et al. Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's Disease. , 2018, Inflammatory bowel diseases.
[118] L. Croner,et al. Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients , 2013, Inflammatory bowel diseases.
[119] Agnieszka Smolinska,et al. The fecal microbiota as a biomarker for disease activity in Crohn’s disease , 2016, Scientific Reports.